Johnson TR - Search Results

1

IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.

Johnson TR, Parker RA, Johnson JE, Graham BS. Johnson TR, et al. Among authors: johnson je. J Immunol. 2003 Feb 15;170(4):2037-45. doi: 10.4049/jimmunol.170.4.2037. J Immunol. 2003. PMID: 12574374

2

The role of IFN in respiratory syncytial virus pathogenesis.

Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS. Durbin JE, et al. Among authors: johnson tr. J Immunol. 2002 Mar 15;168(6):2944-52. doi: 10.4049/jimmunol.168.6.2944. J Immunol. 2002. PMID: 11884466

3

Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.

Johnson TR, Graham BS. Johnson TR, et al. Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.

4

Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection.

Rutigliano JA, Johnson TR, Hollinger TN, Fischer JE, Aung S, Graham BS. Rutigliano JA, et al. Among authors: johnson tr. J Virol. 2004 Mar;78(6):3014-23. doi: 10.1128/jvi.78.6.3014-3023.2004. J Virol. 2004. PMID: 14990720 Free PMC article.

5

Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

Johnson TR, Teng MN, Collins PL, Graham BS. Johnson TR, et al. J Virol. 2004 Jun;78(11):6024-32. doi: 10.1128/JVI.78.11.6024-6032.2004. J Virol. 2004. PMID: 15141000 Free PMC article.

6

Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.

Johnson TR, Varga SM, Braciale TJ, Graham BS. Johnson TR, et al. J Virol. 2004 Aug;78(16):8753-60. doi: 10.1128/JVI.78.16.8753-8760.2004. J Virol. 2004. PMID: 15280483 Free PMC article.

7

Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.

McCurdy LH, Rutigliano JA, Johnson TR, Chen M, Graham BS. McCurdy LH, et al. Among authors: johnson tr. J Virol. 2004 Nov;78(22):12471-9. doi: 10.1128/JVI.78.22.12471-12479.2004. J Virol. 2004. PMID: 15507634 Free PMC article.

8

RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.

Gower TL, Pastey MK, Peeples ME, Collins PL, McCurdy LH, Hart TK, Guth A, Johnson TR, Graham BS. Gower TL, et al. Among authors: johnson tr. J Virol. 2005 May;79(9):5326-36. doi: 10.1128/JVI.79.9.5326-5336.2005. J Virol. 2005. PMID: 15827147 Free PMC article.

9

Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.

Johnson TR, Rothenberg ME, Graham BS. Johnson TR, et al. J Leukoc Biol. 2008 Sep;84(3):748-59. doi: 10.1189/jlb.0907621. Epub 2008 Jun 2. J Leukoc Biol. 2008. PMID: 18519743 Free PMC article.

10

Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.

Liu J, Ruckwardt TJ, Chen M, Johnson TR, Graham BS. Liu J, et al. Among authors: johnson tr. J Virol. 2009 May;83(10):4934-41. doi: 10.1128/JVI.02140-08. Epub 2009 Mar 4. J Virol. 2009. PMID: 19264776 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

590 results

Search Page

Filters